Amidon GL,Lennernas H,Shah VP,Crison JR,- issue JR .1995 .A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12 : 413-420.
Bashir M,Syed HK,Asghar S,Irfan M,Almalki WH,Menshawi SA,Khan IU,Shah PA,Khalid I,Ahmad J,Gohar UF .2020 .Effect of Hydrophilic Polymers on Complexation Efficiency of Cyclodextrins in Enhancing Solubility and Release of Diflunisal. , 12 : 1564.
Brewster ME,Loftsson T .2007 .Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev., 59 : 645-666.
Das S and Subuddhi U .2013 .Cyclodextrin mediated controlled release of naproxen from pH-sensitive chitosan/poly (vinyl alcohol) hydrogels for colon targeted delivery. Ind. Eng. Chem, 52 : 14192-14200.
Dua K,Ramana MV,Singh Sara UV,Himaja M,Agrawal A,Garg V,Pabreja K V .2007 .Investigation of enhancement of solubility of norfloxacin β- cyclodextrin in presence of acidic solubilizing additives. Curr. Drug Deliv., 4 : 21-25.
Evora AO,Castro RA,Maria TM,Rosado MT,Ramos Silva M,Matos Beja A,Canotilho J,Eusébio ME .2011 .Pyrazinamide-diflunisal: A new dual-drug cocrystal (. Cryst. growth des, 11 : 4780-4788.
Fulop Z,Saokham P,Loftsson T .2014 .Sulfobutylether-β-cyclodextrin/chitosan nano-and microparticles and their physicochemical characteristics. Int. J. Pharm., 472 : 282-287.
Gururaj AE,Belakavadi M,Venkatesh DA,Marme D,Salimath BP .2002 .Molecular mechanisms of antiangiogenic effect of curcumin. Biochem. Biophys., Res, 297 : 934-942.
Higuchi T,Connoras KA .1965 .A phase solubility technique. Adv. Anal. Chem, 4 : 117-211.
Hodge RM,Edward GH,Simon GP .1996 .Water absorption and states of water in semicrystalline poly (vinyl alcohol) films (. , 37 : 1371-1376.
Horter D,Dressman JB .2001 .Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Adv. Drug Deliv. Rev., 46 : 75-87.
Jambhekar SS,Breen P .2016 .Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex. Drug Discov. Today, 21 : 356-362.
Patil JS,Kadam DV,Marapur SC,Kamalapur MV .2010 .Inclusion complex system; a novel technique to improve the solubility and bioavailability of poorly soluble drugs: A review. Int. J. Pharm. Sci. Rev. Res., 2 : 29-34.
Kaur A,Bhoop BS,Chhibber S,Sharma G,Gondil VS,Katare OP .2017 .Supramolecular nanoengineered lipidic carriers based on diflunisalphospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int. J. Pharm., 533 : 206-224.
Lincoln SF,Hounslow AM,Coates JH,Villani RP,Schiller RL .1988 .The inclusion of diflunisal by γ- cyclodextrin and permethylatedβ-cyclodextrin. A UVvisible and 19 F nuclear magnetic resonance spectroscopic study. J. Inc. Phenom., 6 : 183-191.
Lipinski CA,Lombardo F,Dominy BW,Feeney PJ .1997 .Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 23 : 3-25.
Loftssona T,Jarvinen T .1999 .Cyclodextrins in ophthalmic drug delivery. Adv. Drug Deliv. Rev., 36 : 59-79.
Mendes C,Buttchevitz A,Kruger JH,Kratz JM,Simoes CM,de Oliveira Benedet P,Oliveira PR,Silva MA .2016 .Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies. Eur. J. Pharm. Sci., 83 : 71-78.
Mura P .2015 .Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review. J. Pharm. Biomed., 113 : 226-238.
Najib NM,Suleiman MS .1989 .Characterization of a diflunisal polyethylene glycol solid dispersion system (. Int. J. Pharm., 51 : 225-232.
Pathak TK,Vasoya NH,Lakhani VK,Modi KB .2010 .Structural and magnetic phase evolution study on needle-shaped nanoparticles of magnesium ferrite. Ceram. Int., 36 : 275-281.
Pignatello R,Ferro M,De Guidi G,Salemi G,Vandelli MA,Guccione S,Geppi M,Forte C,Puglisi G C .2001 .Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100® and RL100®. Int. J. Pharm., 218 : 27-42.
Rodriguez-Espinosa C,Martinez-Oharriz MC,Martin C,Goni MM,Velaz I,Sanchez M .1998 .Dissolution kinetics for coprecipitates of diflunisal with PVP K30. Eur. J Drug Metab. Ph., 23 : 109-112.
Sergey VK,Thorsteinn L VK .2013 .. Cyclodextrins. Int. J. Pharm., 453 : 167-180.
Sideris EE,Valsami GN,Koupparis MA,Macheras PE .1999 .Studies on the interaction of diflunisal ion with cyclodextrins using ion-selective electrode potentiometry (. Eur. J.Pharma. Sci., 7 : 271-278.
Tang P,Li S,Wang L,Yang H,Yan J,Li H J .2015 .Inclusion complexes of chlorzoxazone with β-and hydroxypropyl-β-cyclodextrin: Characterization, dissolution and cytotoxicity. , 131 : 297-305.
Tommasini S,Raneri D,Ficarra R,Calabrò ML,Stancanelli R,Ficarra P,Pharm P .2004 .Improvement in solubility and dissolution rate of flavonoids by complexation with β-cyclodextrin (. , 35 : 379-387.
Veiga F,Fernandes C,Maincent P C .2001 .Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems (. , 27 : 523-532.
Vickers NJ .2017 .Animal Communication: When I'm Calling You, Will You Answer Too?. Curr. Biol, 27 : R7113-15.
Wang L,Tan B,Zhang H,Deng Z H .2013 .Pharmaceutical cocrystals of diflunisal with nicotinamide or isonicotinamide. Org. Process Res. Dev., 17 : 1413-1418.
Wang X,Luo Z,Xiao Z Z .2014 .Preparation, characterization and thermal stability of β- cyclodextrin/soybean lecithin inclusion complex. Carbohydr, 101 : 1027-1032.
Zoeller T,Dressman JB,Klein S JB .2012 .Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions. Int. J. Pharm., 430 : 176-183.
Zugasti ME,Zornoza A,del Mar Goñi M,Isasi JR,Vélaz I,Martín C,Sánchez M,Martínez-Ohárriz MC .2009 .Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. Drug Dev, 35 : 1264-1270.